Drug Topics
OCTOBER 2, 2022
Jordan Cardinal, EM/CC PharmD, a Medical Science Liaison in Integrated Diagnostic Solutions at BD, joins Drug Topics® to discuss the current outlook on the upcoming 2022-2023 flu season, and how the prevalence of the BA.5 variant of the SARS-CoV-2 virus might affect the health care outlook over the coming months.
BioPharm
OCTOBER 2, 2022
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Guardian - Pharmaceutical Industry
OCTOBER 2, 2022
London museum bows to years of pressure and removes signs bearing name of family associated with OxyContin crisis Campaigners calling for the name Sackler to be dropped from cultural landmarks are celebrating this weekend. Their smiles mark five years of demonstrations and dramatic stunts as another major arts institution – London’s Victoria and Albert Museum – takes down signs acknowledging the financial contribution from this wealthy family.
BioPharm
OCTOBER 2, 2022
Advances in Real-Time Supply Chain Operation Technology Can Address Drug Product Security Challenges.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
OCTOBER 2, 2022
As individuals in a society, all people have implicit, or unconscious, beliefs that they have been socialized to hold; however, health care professionals’ implicit biases can impact patients’ lives.
BioPharm
OCTOBER 2, 2022
Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
BioPharm
OCTOBER 2, 2022
A simplified downstream process can save time and costs but requires enabling technologies.
Board Vitals - Pharmacist
OCTOBER 2, 2022
Are you preparing to take your PANRE exam? As part of the NCCPA’s certification maintenance process, PA-C designees must pass the Physician Assistant National Recertifying Exam (PANRE) by the end of the tenth year of their certification maintenance cycle. With so many different Online PANRE exam review question banks available, how do you know which one best fits your needs?
BioPharm
OCTOBER 2, 2022
Both demand for and investment in fill/finish capacity continue to rise.
BioPharm
OCTOBER 2, 2022
The industry revisits the pros and cons of microbial fermentation at scale for biotherapeutics.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
BioPharm
OCTOBER 2, 2022
Using a minimum valuable product and process approach would make it is possible to discipline and structure the development of biopharmaceuticals in the fastest way possible.
BioPharm
OCTOBER 2, 2022
Assessment of peripheral blood protein glycosylation has recently become scalable, providing a new domain for biomarker research.
BioPharm
OCTOBER 2, 2022
BFS technology can help maintain sterility during the biologics manufacturing process.
BioPharm
OCTOBER 2, 2022
There are many benefits of employing a reformulation strategy, but companies must also overcome a variety of challenges too.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Expert insights. Personalized for you.
247 
Let's personalize your content